Nanjing Well Pharmaceutical Group Co.,Ltd. (SHA:603351)
China flag China · Delayed Price · Currency is CNY
24.82
-0.61 (-2.40%)
Mar 20, 2026, 3:00 PM CST

SHA:603351 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
3,3623,3263,5722,9305,1182,979
Market Cap Growth
-1.63%-6.86%21.88%-42.75%71.80%-9.60%
Enterprise Value
3,6103,6013,9493,2605,2102,871
Last Close Price
24.8224.2225.6420.8037.1721.31
PE Ratio
22.7722.7231.8330.8450.4929.66
PS Ratio
2.562.573.092.644.914.05
PB Ratio
1.901.952.241.983.692.29
P/TBV Ratio
2.042.092.402.113.922.44
P/FCF Ratio
22.8819.5375.71---
P/OCF Ratio
16.4515.0029.7026.89-31.93
EV/Sales Ratio
2.752.783.422.945.003.90
EV/EBITDA Ratio
11.1613.0519.7218.0532.1420.17
EV/EBIT Ratio
20.1621.2729.8827.8642.5526.59
EV/FCF Ratio
24.5721.1483.72---
Debt / Equity Ratio
0.350.280.310.290.140.09
Debt / EBITDA Ratio
1.891.692.392.261.210.82
Debt / FCF Ratio
4.162.8310.32---
Net Debt / Equity Ratio
0.140.140.210.220.08-0.12
Net Debt / EBITDA Ratio
0.770.851.641.800.66-1.10
Net Debt / FCF Ratio
1.641.376.96-2.60-0.430.83
Asset Turnover
0.540.560.520.560.600.48
Inventory Turnover
5.155.045.025.275.924.47
Quick Ratio
0.930.820.720.480.711.20
Current Ratio
1.291.201.080.811.101.63
Return on Equity (ROE)
8.48%8.80%7.10%6.59%7.46%7.91%
Return on Assets (ROA)
4.60%4.54%3.74%3.68%4.40%4.36%
Return on Invested Capital (ROIC)
7.33%7.39%6.37%5.93%7.83%9.34%
Return on Capital Employed (ROCE)
9.50%9.50%7.70%7.50%8.60%8.10%
Earnings Yield
4.39%4.40%3.14%3.24%1.98%3.37%
FCF Yield
4.37%5.12%1.32%-4.26%-4.83%-6.35%
Dividend Yield
1.57%1.65%1.17%1.35%0.81%1.41%
Payout Ratio
45.24%37.88%47.61%56.70%44.64%46.87%
Buyback Yield / Dilution
0.43%-0.29%-1.00%-0.35%-2.25%-1.83%
Total Shareholder Return
1.96%1.36%0.17%1.00%-1.44%-0.42%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.